Immediate Management of Postpartum Hemorrhage with Respiratory Distress, Seizures, and Coagulopathy
This clinical presentation suggests amniotic fluid embolism (AFE) or severe hemorrhagic shock with multi-organ failure, requiring immediate resuscitation, airway management, correction of coagulopathy, and hemorrhage control in an intensive care setting.
Initial Resuscitation and Stabilization
Activate a massive transfusion protocol immediately for blood loss exceeding 1,500 mL, as rapid team-based response minimizes morbidity and mortality 1. The postpartum period represents a particularly vulnerable time with risks of cardio-respiratory decompensation, sepsis, and hemorrhage 2.
Airway and Respiratory Management
- Secure the airway immediately given respiratory distress and seizure activity to prevent aspiration and ensure adequate oxygenation 2.
- Consider assisted ventilation strategies with appropriate intensive care unit backup 2.
- Apply positive end-expiratory pressure if needed to maintain adequate oxygenation 2.
- Provide oxygen therapy to maintain normal saturations 2.
Seizure Management
- Administer magnesium sulfate as first-line therapy if eclampsia is suspected, though the constellation of symptoms suggests AFE as more likely 2.
- Protect the patient from injury during seizure activity.
- Consider benzodiazepines if seizures persist despite magnesium.
Hemorrhage Control
Medical Management
Administer oxytocin 5-10 IU slow IV or intramuscular immediately as the most important and effective component for uterine atony management 2, 1. Oxytocin is more effective than misoprostol and has fewer adverse effects 1.
- Avoid prostaglandin F2α and ergometrine in patients with respiratory distress, as prostaglandin F2α causes bronchoconstriction and ergometrine may cause bronchospasm, particularly with general anesthetics 2.
- Consider additional uterotonics if oxytocin alone is insufficient 1, 3.
- Apply uterine massage and consider uterine tamponade with balloon catheter if bleeding continues 2.
Coagulopathy Correction
Initiate early transfusion of plasma with high plasma-to-red blood cell ratios in massive postpartum hemorrhage complicated by coagulopathy 4. The "washout phenomenon" leading to coagulopathy must be corrected promptly 5.
- Administer tranexamic acid for hemorrhage complicated by coagulopathy, as it has been shown to reduce mortality in obstetric hemorrhage 4, 5.
- Consider fibrinogen concentrates if fibrinogen levels are critically low 4.
- Perform rapid laboratory assessment of coagulopathy including PT, PTT, fibrinogen, and platelet count 4.
- Replace clotting factors and platelets based on laboratory results and clinical bleeding 4, 5.
Diagnostic Evaluation
Perform rapid clinical assessment using the "Four T's" mnemonic to identify the cause: Tone (uterine atony), Trauma (lacerations, rupture), Tissue (retained placenta), and Thrombin (coagulopathy) 1.
- Examine for genital tract lacerations, hematomas, or uterine rupture 2, 1.
- Assess for retained placental tissue 2, 1.
- Consider imaging with ultrasound or CT angiography if the bleeding source is unclear or if vascular anomalies are suspected 2.
Surgical and Interventional Options
If conservative measures fail:
- Uterine artery embolization may be performed if the patient is hemodynamically stable enough for transfer to interventional radiology 2, 3.
- Surgical ligation of uterine or internal iliac arteries 2, 3.
- Peripartum hysterectomy should be performed without delay if other measures fail, as timely hysterectomy saves lives 3, 5.
Critical Care Considerations
Transfer to intensive care unit immediately given the multi-system involvement with respiratory failure, neurological compromise, and coagulopathy 2. The level of care must be determined in a multidisciplinary setting balancing obstetric and critical care needs 2.
Thromboprophylaxis
- Consider thromboprophylaxis with low-molecular-weight heparin once hemorrhage is controlled and coagulopathy corrected, as postpartum venous thromboembolic risk is increased with immobility 2, 6.
- Postpartum prophylaxis should typically continue for 6 weeks, particularly with additional risk factors such as emergency cesarean section, blood loss >1L, or BMI ≥30 kg/m² 6.
Common Pitfalls
- Underestimating blood loss is common; use objective measures like obstetric shock index rather than visual estimation 5.
- Delaying definitive surgical intervention (hysterectomy) when conservative measures fail increases mortality 5.
- Failing to activate massive transfusion protocols early enough 1, 4.
- Using respiratory-compromising uterotonics (prostaglandins, ergometrine) in patients with respiratory distress 2.